% This is the RIPE Database query service.
% The objects are in RPSL format.
%
% The RIPE Database is subject to Terms and Conditions.
% See https://docs.db.ripe.net/terms-conditions.html
% Information related to 'AS12753'
% Abuse contact for 'AS12753' is '[email protected]'
aut-num: AS12753
as-name: TEVA-AS
org: ORG-TPIL1-RIPE
import: from AS9116
action pref=100;
accept ANY
import: from AS8551
action pref=100;
accept ANY
export: to AS9116
announce AS12753
export: to AS8551
announce AS12753
admin-c: MF1146-RIPE
tech-c: MF1146-RIPE
remarks: Will be using 192.115.248.0/22
status: ASSIGNED
notify: [email protected]
mnt-by: NV-MNT-RIPE
mnt-by: RIPE-NCC-END-MNT
created: 2002-05-31T04:46:14Z
last-modified: 2017-11-15T09:15:10Z
source: RIPE
sponsoring-org: ORG-NL5-RIPE
organisation: ORG-TPIL1-RIPE
org-name: Teva Pharmaceutical Industries Limited
country: IL
org-type: OTHER
address: Basel 5 Petah-Tikva Israel
e-mail: [email protected]
abuse-c: AR28884-RIPE
mnt-ref: NV-MNT-RIPE
mnt-by: NV-MNT-RIPE
created: 2009-12-20T04:50:59Z
last-modified: 2022-12-01T17:28:28Z
source: RIPE
person: Michael Fainer
address: Teva Ltd.
address: Basel 5 Petah-Tikva Israel
phone: +972 3 9267501
fax-no: +972 3 9267439
e-mail: [email protected]
nic-hdl: MF1146-RIPE
notify: [email protected]
mnt-by: ISOC-MNT
created: 2002-05-31T04:38:52Z
last-modified: 2002-05-31T04:38:52Z
source: RIPE
% This query was served by the RIPE Database Query Service version 1.114 (BUSA)